Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

The U.S. has just approved a powerful new weapon in the fight against HIV: a twice-a-year prevention shot called Yeztugo. Made by Gilead Sciences, the injectable treatment slashes the risk of HIV ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier in June revoking notices they ...

Kathy Seward MacKay lost her husband in 1997 because of tainted blood-clotting products. She’s worried about history ...

The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

The Genesee County Health Department is offering no-cost testing during National HIV Testing Day at the Genesee Free Medical ...